Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-016020

Director acquired 822 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2024-08-01 Other acquisition 10b5-1 +44 $1.47 $65 34,775 D
Jones James Director 2024-08-02 Other acquisition 10b5-1 +40 $1.44 $58 34,815 D
Jones James Director 2024-08-05 Other acquisition 10b5-1 +19 $1.42 $27 34,834 D
Jones James Director 2024-08-06 Other acquisition 10b5-1 +39 $1.46 $57 34,873 D
Jones James Director 2024-08-07 Other acquisition 10b5-1 +44 $1.50 $66 34,917 D
Jones James Director 2024-08-08 Other acquisition 10b5-1 +28 $1.45 $41 34,945 D
Jones James Director 2024-08-12 Other acquisition 10b5-1 +25 $1.43 $36 34,970 D
Jones James Director 2024-08-13 Other acquisition 10b5-1 +70 $1.43 $100 35,040 D
Jones James Director 2024-08-14 Other acquisition 10b5-1 +44 $1.45 $64 35,084 D
Jones James Director 2024-08-15 Other acquisition 10b5-1 +7 $1.38 $10 35,091 D
Jones James Director 2024-08-16 Other acquisition 10b5-1 +45 $1.42 $64 35,136 D
Jones James Director 2024-08-19 Other acquisition 10b5-1 +44 $1.38 $61 35,180 D
Jones James Director 2024-08-20 Other acquisition 10b5-1 +45 $1.35 $61 35,225 D
Jones James Director 2024-08-21 Other acquisition 10b5-1 +36 $1.39 $50 35,261 D
Jones James Director 2024-08-22 Other acquisition 10b5-1 +44 $1.40 $62 35,305 D
Jones James Director 2024-08-23 Other acquisition 10b5-1 +42 $1.38 $58 35,347 D
Jones James Director 2024-08-26 Other acquisition 10b5-1 +50 $1.37 $69 35,397 D
Jones James Director 2024-08-27 Other acquisition 10b5-1 +29 $1.40 $41 35,426 D
Jones James Director 2024-08-28 Other acquisition 10b5-1 +50 $1.40 $70 35,476 D
Jones James Director 2024-08-29 Other acquisition 10b5-1 +50 $1.41 $71 35,526 D
Jones James Director 2024-08-30 Other acquisition 10b5-1 +27 $1.35 $36 35,553 D
Loading xslF345X05/marketforms-66912.xml…